Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 6
1976 6
1977 8
1978 4
1979 2
1980 5
1981 5
1982 4
1983 8
1984 7
1985 7
1986 13
1987 27
1988 8
1989 7
1990 9
1991 6
1992 5
1993 4
1994 3
1995 3
1996 3
1997 2
1998 3
1999 1
2002 5
2003 1
2004 3
2005 2
2006 2
2007 8
2008 3
2009 2
2010 2
2011 3
2012 4
2013 4
2014 4
2015 5
2016 7
2017 7
2018 11
2019 10
2020 17
2021 12
2022 15
2023 13
2024 15
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Results by year

Filters applied: . Clear all
Page 1
Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Penha MA, et al. JAMA Dermatol. 2024 Jun 1;160(6):600-605. doi: 10.1001/jamadermatol.2024.0284. JAMA Dermatol. 2024. PMID: 38598226 Free PMC article. Clinical Trial.
OBJECTIVE: To compare the efficacy, safety, and tolerability of daily oral minoxidil, 5 mg, vs twice-daily topical minoxidil, 5%, for 24 weeks in the treatment of male AGA. ...INTERVENTIONS: Participants were randomized 1:1 into 2 groups: oral minoxidil, 5 mg …
OBJECTIVE: To compare the efficacy, safety, and tolerability of daily oral minoxidil, 5 mg, vs twice-daily topical minoxidil, …
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. Olsen EA, et al. J Am Acad Dermatol. 2002 Sep;47(3):377-85. doi: 10.1067/mjd.2002.124088. J Am Acad Dermatol. 2002. PMID: 12196747 Clinical Trial.
An increased occurrence of pruritus and local irritation was observed with 5% topical minoxidil compared with 2% topical minoxidil. CONCLUSION: In men with AGA, 5% topical minoxidil was clearly superior to 2% topical minoxidil and placebo in increasing …
An increased occurrence of pruritus and local irritation was observed with 5% topical minoxidil compared with 2% topical minoxidil …
Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.
Asilian A, Farmani A, Saber M. Asilian A, et al. J Cosmet Dermatol. 2024 Mar;23(3):949-957. doi: 10.1111/jocd.16086. Epub 2023 Nov 29. J Cosmet Dermatol. 2024. PMID: 38031516 Clinical Trial.
However, low-dose oral minoxidil has been used off-label with good clinical efficacy and safety. AIM: To compare the effectiveness and safety of topical minoxidil as a first-choice treatment of androgenetic alopecia versus 1 mg daily oral minoxidil. ...Theref …
However, low-dose oral minoxidil has been used off-label with good clinical efficacy and safety. AIM: To compare the effectiveness an …
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD. Lucky AW, et al. J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014. J Am Acad Dermatol. 2004. PMID: 15034503 Clinical Trial.
The 5% topical minoxidil group demonstrated statistical superiority over the 2% topical minoxidil group in the patient assessment of treatment benefit at week 48. ...At week 48, the 5% topical minoxidil group demonstrated statistical superiority over the 2% t …
The 5% topical minoxidil group demonstrated statistical superiority over the 2% topical minoxidil group in the patient assessm …
Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Pakhomova EE, Smirnova IO. Pakhomova EE, et al. Int J Mol Sci. 2020 Sep 6;21(18):6516. doi: 10.3390/ijms21186516. Int J Mol Sci. 2020. PMID: 32899959 Free PMC article. Clinical Trial.
MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combination. The clinical efficacy of the therapy was evaluated by the dynamics of morphometric of hairs. ...RESULTS: PRP treatment was more effec …
MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combin …
Ketoconazole shampoo: effect of long-term use in androgenic alopecia.
Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE. Piérard-Franchimont C, et al. Dermatology. 1998;196(4):474-7. doi: 10.1159/000017954. Dermatology. 1998. PMID: 9669136 Clinical Trial.
METHOD: The effect of 2% KCZ shampoo was compared to that of an unmedicated shampoo used in combination with or without 2% minoxidil therapy. RESULTS: Hair density and size and proportion of anagen follicles were improved almost similarly by both KCZ and minoxidil r …
METHOD: The effect of 2% KCZ shampoo was compared to that of an unmedicated shampoo used in combination with or without 2% minoxidil …
Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
Rossi A, Caro G. Rossi A, et al. J Cosmet Dermatol. 2024 Feb;23(2):502-509. doi: 10.1111/jocd.15953. Epub 2023 Oct 5. J Cosmet Dermatol. 2024. PMID: 37798906 Clinical Trial.
PURPOSE: Topical minoxidil (MNX) 2%-5% and oral finasteride (F) 1 mg/day are the only two pharmacological treatments authorized for androgenetic alopecia (AGA). ...
PURPOSE: Topical minoxidil (MNX) 2%-5% and oral finasteride (F) 1 mg/day are the only two pharmacological treatments authorized for a …
296 results